title: Taxane-induced nail changes: incidence, clinical presentation and outcome.
abstract: The clinical characteristics of nail changes in seven patients receiving taxane-containing chemotherapy are described. They include nail pigmentation, subungual hematoma, Beau's lines and onycholysis and subungual suppuration. The incidence of such changes (ranging from 0% to 44%) is reviewed from a Medline search of the literature.
authors.affiliation: Clinical Oncology, University of Udine, Udine, Italy.
authors.forename: A M
authors.initials: AM
authors.lastname: Minisini
authors.forename: A
authors.initials: A
authors.lastname: Tosti
authors.forename: A F
authors.initials: AF
authors.lastname: Sobrero
authors.forename: M
authors.initials: M
authors.lastname: Mansutti
authors.forename: B M
authors.initials: BM
authors.lastname: Piraccini
authors.forename: C
authors.initials: C
authors.lastname: Sacco
authors.forename: F
authors.initials: F
authors.lastname: Puglisi
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects* / Q000627:therapeutic use; D000077143:Docetaxel; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D009260:Nail Diseases / Q000139:chemically induced* / Q000453:epidemiology; D017239:Paclitaxel / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D043823:Taxoids
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D043823:Taxoids; D000077143:Docetaxel; D017239:Paclitaxel